Aardvark Therapeutics, Inc.(AARD)
$1.15-0.11 (-8.73%)
AARD
Aardvark Therapeutics, Inc. earnings date
$1.15
At close:-0.11 (-8.73%)
Want to see AARD full AI Analyst Report?
Aardvark Therapeutics, Inc. (AARD) Q2 2026 Earnings Report
142 Followers
AARD Q2 2026 EPS Results
- Actual EPS
- -$0.66
- Consensus EPS
- -$0.87
- Beat/Miss
- Beat by +$0.21
- One Year Ago EPS
- -$0.66
AARD Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- After Close
- Conference Call
- Tuesday, August 11, 2026
AARD Upcoming Earnings
Aardvark Therapeutics, Inc.'s next earnings date is estimated for April 5, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
AARD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 05, 2027 | 2026 (Q4) | -0.74- | -0.99 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.72-0.88 | -0.75 | -17.33% (-0.13) | |
| Aug 11, 2026 | 2026 (Q2) | -0.87-0.66 | -0.66 | 0.00% (+0.00) | |
| May 07, 2026 | 2026 (Q1) | -0.88-0.99 | -0.71 | -39.44% (-0.28) | |
| Mar 23, 2026 | 2025 (Q4) | -0.83-0.81 | -0.43 | -86.21% (-0.38) | |
| Nov 13, 2025 | 2025 (Q3) | -0.80-0.75 | -0.2 | -282.65% (-0.55) | |
| Aug 13, 2025 | 2025 (Q2) | -0.60-0.66 | -2.13 | 68.98% (+1.47) | |
| May 14, 2025 | 2025 (Q1) | ―- | -0.85 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -0.67-0.71 | -0.85 | 16.57% (+0.14) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

